Bernstein A B, Thompson G B, Harlan L C
Prospective Payment Assessment Commission, Washington, DC 20024.
Med Care. 1991 Mar;29(3):196-209.
Data from the Cancer Control Supplement of the 1987 Health Interview Survey (NHIS), a nationally representative sample of the United States population, was used to examine rates of six screening tests for cancer. The rates of screening were compared for people who receive their usual source of medical care in an HMO or prepaid group practice versus those who receive it in the fee-for-service sector. The purpose of this article is to determine whether HMOs remain more likely to offer cancer screening examinations than the fee-for-service sector. Results indicate that for five of six screening tests examined (Pap smear, mammography, breast physical examination, digital rectal examination, and blood stool test), members of HMOs are significantly more likely to have received the test within the last 3-year period. These results hold in a multivariate analysis when many factors correlated with selection into HMOs, health status, and use of medical services are controlled for, although results are only generalizable to whites. Future research should focus on why the rates for five of the six cancer screening tests examined are higher in HMO settings, and how we can use the HMO experience to improve consensus as to the usefulness of the tests in the non-HMO physician pool, and ultimately increase rates of screening tests in the non-HMO population.
来自1987年健康访谈调查(NHIS)癌症控制补充调查的数据,该调查是美国人口具有全国代表性的样本,用于检查六种癌症筛查测试的比率。比较了在健康维护组织(HMO)或预付费团体诊所接受常规医疗服务的人群与在按服务收费部门接受常规医疗服务的人群的筛查比率。本文的目的是确定HMO是否比按服务收费部门更有可能提供癌症筛查检查。结果表明,在所检查的六项筛查测试中的五项(巴氏涂片检查、乳房X光检查、乳房体格检查、直肠指检和粪便潜血试验)中,HMO的成员在过去三年中接受该测试的可能性显著更高。当控制了许多与加入HMO、健康状况和医疗服务使用相关的因素时,这些结果在多变量分析中仍然成立,尽管结果仅适用于白人。未来的研究应关注为什么在所检查的六项癌症筛查测试中的五项在HMO环境中的比率更高,以及我们如何利用HMO的经验来提高非HMO医生群体对这些测试有用性的共识,并最终提高非HMO人群的筛查测试比率。